POMC and adrenal gland hyperfunction: These patients had pre-PRRT biochemistry demonstrating ACTH-dependent hypercortisolism managed with metyrapone (3/5), ketoconazole (1/5) and dual metyrapone/ketoconazole therapy (1/5).